Controlling Nutritional Status (CONUT) as a prognostic immunonutritional biomarker for gastric cancer after curative gastrectomy: a propensity score-matched analysis
In clinical practice, it is not unusual to treat oncologic patients whose tumor markers are within normal range, even with advanced cancer. The Controlling Nutritional Status (CONUT) score could provide a useful nutritional and immunological prognostic biomarker for cancer patients. In this study, we assessed the prognostic value of the CONUT score for patients with gastric cancer, including a subgroup analysis with stratification based on serum carcinoembryonic antigen (CEA) level.
We retrospectively reviewed the medical records of 368 consecutive patients who underwent curative laparoscopy-assisted gastrectomy. The prognostic value of the CONUT score was compared between patients with a low (≤ 2) and high (≥ 3) score, with propensity score matching (PSM) used to control for biasing covariates (Depth of tumor, Lymph node metastasis, pathological TNM (pTNM) stage).
Overall survival (OS) among all patients was independently predicted by the tumor stage (hazard ratio (HR): 2.231, p = 0.001), the CONUT score (HR: 2.254, p = 0.001), and serum CEA level (HR: 1.821, p = 0.025). Among patients with a normal preoperative serum CEA level, tumor stage (HR: 2.350, p = 0.007), and the CONUT score (HR: 1.990, p = 0.028) were independent prognostic factors of OS. In the high serum CEA level group, tumor size (HR: 2.930, p = 0.015) and the CONUT score (HR: 3.707, p = 0.004) were independent prognostic factors of OS.
It is advantageous to use both CEA level and the CONUT score to assess the prognosis of patients with gastric cancer, which reflect both tumor-related factors and host-related factors, respectively.
KeywordsGastric cancer CONUT CEA Overall survival
This study received no external sources of funding.
Compliance with ethical standards
Drs. Noriyuki Hirahara, Yoshitsugu Tajima, Yusuke Fujii, Shunsuke Kaji, Tetsu Yamamoto, Ryoji Hyakudomi, Takahito Taniura, and Yasunari Kawabata have no conflicts of interest or financial ties to disclose.
- 3.Hirahara N, Tajima Y, Fujii Y, Kaji S, Yamamoto T, Hyakudomi R, Taniura T, Kawabata Y (2018) Prognostic nutritional index as a predictor of survival in resectable gastric cancer patients with normal preoperative serum carcinoembryonic antigen levels: a propensity score matching analysis. BMC Cancer 13;18(1):285. https://doi.org/10.1186/s12885-018-4201-4 CrossRefPubMedPubMedCentralGoogle Scholar
- 4.Kurahara H, Maemura K, Mataki Y, Sakoda M, Iino S, Hiwatashi K, Kawasaki Y, Arigami T, Ishigami S, Kijima Y, Shinchi H, Takao S, Natsugoe S (2015) Prognostication by inflammation-based score in patients with locally advanced pancreatic cancer treated with chemoradiotherapy. Pancreatology 15(6):688–693. https://doi.org/10.1016/j.pan.2015.09.015 CrossRefPubMedGoogle Scholar
- 6.Ignacio de Ulibarri J, Gonzalez-Madrono A, de Villar NG, González P, González B, Mancha A, Rodríguez F, Fernández G (2005) CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp 20(1):38–45Google Scholar
- 8.Shao Y, Sun X, He Y, Liu C, Hui Liu (2015) Elevated levels of serum tumor markers cea and ca15-3 are prognostic parameters for different molecular subtypes of breast cancer. PLoS ONE 10(7):e0133830. https://doi.org/10.1371/journal.pone.0133830 (Published online 2015 Jul 24).CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Arrieta O, Saavedra-Perez D, Kuri R, Aviles-Salas A, Martinez L, Mendoza-Posada D, Castillo P, Astorga A, Guzman E, Garza J (2009) Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis. BMC Cancer 9:119. https://doi.org/10.1186/1471-2407-9-119 (Published online 2009 Apr 22).CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Sobin L, Gospodarowicz M, Wittekind C (eds) (2010) International union against Cancer (UICC). TNM classification of malignant tumors, 7th edn. Wiley-Blackwell, New YorkGoogle Scholar
- 15.Milsom C, Yu J, May L, Meehan B, Magnus N, Al-Nedawi K, Luyendyk J, Weitz J, Klement P, Broze G, Mackman N, Rak J (2007) The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression. Thromb Res 120. Suppl 2:S82-91. Erratum in: Thromb Res. 2008;123(1):187-190/bib>CrossRefGoogle Scholar
- 16.Hirahara N, Matsubara T, Hayashi H, Takai K, Nakada S, Tajima Y (2018) Prognostic importance of controlling nutritional status in patients undergoing curative thoracoscopic esophagectomy for esophageal cancer. Am J Ther 25(5):e524–e532. https://doi.org/10.1097/MJT.0000000000000414 CrossRefPubMedGoogle Scholar
- 17.Akamine T, Toyokawa G, Matsubara T, Kozuma Y, Haratake N, Takamori S, Katsura M, Takada K, Shoji F, Okamoto T, Maehara Y (2017) Significance of the preoperative CONUT score in predicting postoperative disease-free and overall survival in patients with lung adenocarcinoma with obstructive lung cancer. Anticancer Res 37(5):2735–2742CrossRefGoogle Scholar
- 19.Zhang G, Zhang D, Wu J, Zhang F, Zhu Z, Chen K, Zhang N, Jin J, Feng J, Lin N, Zhang Y, Yu H, Su D, Ying L (2018) Low serum levels of pre-surgical total cholesterol are associated with unfavorable overall survival in patients with operable non-small cell lung cancer. Clin Lab 64(3):321–327. https://doi.org/10.7754/Clin.Lab.2017.170823 CrossRefPubMedGoogle Scholar
- 20.Lim JA, Oh CS, Yoon TG, Lee JY, Lee SH, Yoo YB, Yang JH, Kim SH (2018) The effect of propofol and sevoflurane on cancer cell, natural killer cell, and cytotoxic T lymphocyte function in patients undergoing breast cancer surgery: an in vitro analysis. BMC Cancer 7;18(1):159. https://doi.org/10.1186/s12885-018-4064-8 CrossRefPubMedPubMedCentralGoogle Scholar
- 21.Lucijanic M, Veletic I, Rahelic D, Pejsa V, Cicic D, Skelin M, Livun A, Tupek KM, Stoos-Veic T, Lucijanic T, Maglicic A, Kusec R (2018) Assessing serum albumin concentration, lymphocyte count and prognostic nutritionalindex might improve prognostication in patients with myelofibrosis. Wien Klin Wochenschr 130(3–4):126–133. https://doi.org/10.1007/s00508-018-1318-z CrossRefPubMedGoogle Scholar
- 23.Christou N, Perraud A, Blondy S, Jauberteau MO, Battu S, Mathonnet M (2017) The extracellular domain of E cadherin linked to invasiveness in colorectal cancer: a new resistance and relapses monitoring serum-bio marker? J Cancer Res Clin Oncol 143(7):1177–1190. https://doi.org/10.1007/s00432-017-2382-x CrossRefPubMedGoogle Scholar